Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 426 results for "erbitux"

Merck: Chinese Phase III Study With Erbitux Plus FOLFOX Meets Primary Endpoint
Nasdaq

Merck reports positive results form Chinese Phase III TAILOR t...

Merck has reported that the Chinese Phase III TAILOR study has demonstrated positive results of Erbitux (cetuximab) plus Folfox chemotherapy, compared with Folfox alone in patients with RAS wild-type metastatic colorectal cancer (mCRC). The ... Drug Development Technology, 1 month ago
[x]  

1 images for "erbitux"

Nasdaq, 1 month ago

Europe Erbitux Industry 2016 Market Research Report

Request Sample Report @ The Europe Erbitux Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Erbitux Industry. The report provides a basic overview of the industry including definitions, ...
 MyNewsDesk3 weeks ago Gastric Cancer Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019  Press Release Ping2 weeks ago Oncology/Cancer Drugs Market 2016-2020: Global Industry Growth, Analysis and Report Forecast  Digital Journal3 weeks ago GLOBAL & USA CANCER IMMUNOTHERAPY MARKET ANALYSIS TO 2020: Antibody Drug Conjugates (ADCs), Bispecific Monoclonal Antibodies, Cancer Vaccines, Cytokines, Interferons, Chimeric Antigen Receptor (CAR) T-Cell Therapy, PD-1/PD-L1 inhibitors  MyNewsDesk3 weeks ago

Cetuximab Improves Long-Term Disease Control in HPV-Negative HNSCC

Adding cetuximab (Erbitux) to induction chemotherapy and hyperfractionated or accelerated chemoradiation therapy (CRT) produced long-term control for patients with HPV-negative, locoregionally advanced head and neck squamous cell carcinoma ...
 Targeted Oncology1 month ago

2016 Update of Biosimilar & Biosuperior Therapeutic Antibodies - Competitor Analysis: MarketResearchReports.Biz

MarketResearchReports.Biz has announced addition of new report Competitor Analysis: Biosimilar & Biosuperior Therapeutic Antibodies - 2016 Update to its database. This press release was orginally distributed by SBWire Albany, NY -- (SBWIRE) -- ...
 Digital Journal1 day ago Competitor Analysis: Biosimilar & Biosuperior Therapeutic Antibodies - 2016 Update  Global Information Inc5 days ago

4 Dividend-Paying Stocks to Help Ride Out the Coming Volatile Summer

Source: ThinkstockThe rally that took place this week has been great, and the reasons from strategists are many, but one thing is for sure: things could get a little more dicey this summer. The first consideration of course is whether the Federal ...
 24/7 Wall St4 days ago

Inside Bristol-Myers Squibb's Oncology Segment

What's Really Driving Bristol-Myers Squibb's Valuation? ( Continued from Prior Part ) The Oncology segment With strong performance of Opdivo, Bristol-Myers Squibb's (BMY) Oncology segment has emerged as the largest revenue contributor for the ...
 Yahoo! Finance UK and Ireland4 days ago Behind Bristol-Myers Squibb's Continued Growth in 1Q16  Yahoo! 7 Finance5 days ago
[x]  

PlncRNA-1 induces apoptosis through the Her-2 pathway in prostate cancer cells

ORIGINAL ARTICLE Ahead of print publication Qing Yang 1 , Zi-Lian Cui 2 , Qin Wang 3 , Xun-Bo Jin 4 , Yong Zhao 4 , Mu-Wen Wang 4 , Wei Song 4 , Hua-Wei Qu 4 , Wei-Ting Kang 4 1 Department of Breast and Thyroid Surgery, Shandong Provincial ...
 Asian Journal of Andrology4 days ago
Washington Post

(May-25) - If you get colon cancer, your prognosis depends partly on where it started

By Laurie McGinley People with cancer that starts on the left side of their colon live significantly longer than those with right-side tumors, according to a new study that provides insights into how best to match drugs to patients with advanced ...
 Colorectal Cancer Association of Canada5 days ago Colon cancer patients survive longer when their tumors start on the left side  Washington Post1 week ago

4 UBS Most Preferred Pharmaceutical Stocks That Pay Big Dividends

Source: Wikimedia CommonsNeedless to say, the health care sector, especially pharmaceuticals and biotech, have taken a rhetorical beating from politicians looking to force the blame for high drug prices on some of the top companies. While prices on ...
 24/7 Wall St6 days ago
Arabstoday.net

A to Z List of Cancer Drugs

This list includes more than 200 cancer drug information summaries from NCI . The summaries provide consumer-friendly information about cancer drugs and drug combinations. Summaries for individual cancer drugs cover the uses of these drugs, ...
 Arabstoday.net6 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - erbitux
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less